Draegerwerk AG & Co. KGaA · XETR:DRW8
Draegerwerk AG & Co. KGaA — Drägerwerk AG & Co. KGaA — Q3 2005 Earnings Presentation
25 slides from Draegerwerk AG & Co. KGaA's earnings presentation, Nov 10, 2005
Slide 1: Drägerwerk AG Conference Call
Drägerwerk AG Conference Call November 10, 2005 1 November 05
Slide 2: Content
Content 1. Dräger Medical 2. Dräger Safety 3. Dräger Group 4. Appendix 2 November 05
Slide 3: Dräger Medical
Dräger Medical »Because you care« 3 November 05
Slide 4: Dräger Medical Highlights Q3 2005
Dräger Medical Highlights Q3 2005 • Double-digit increase in order entry and net sales versus previous year - 9M: America with order entry plus 41,3% - 9M: Europe order entry plus 24.3% • Higher than proportional increase in EBIT • Expenses for R&D continue on a high level - 9M: 59.4 mn €, 8.0% of n
Slide 5: Dräger Medical Q3 2005 / 9M 2005
Dräger Medical Q3 2005 / 9M 2005 mn € Q3 2004 Q3 2005 Change 9M 2004 9M 2005 Change Order entry 246.8 275.9 +11.8% 704.2 821.4 +16.6% Net sales 226.3 255.3 +12.8% 662.8 747.4 +12.8% Operating EBIT 6.6 15.1 +128.8% 34.4 49.2 +43.0% EBIT margin 2.9% 5.9% 5.2% 6.6% Non-recurring expenses 2.5 1.2 7.2 1.
Slide 6: Dräger Medical Key Figures/Development
Dräger Medical Key Figures/ Development >= 7% Net Sales 1,023 mn € 747 663 437 492 266 255 360 200 226 237 226 Q1 Q1 Q2 Q2 Q3 Q3 Q4 Q4 2004 2005 2004 2005 2004 2005 2004 2005 >= 7% EBIT 94 mn € 59 49 28 34 35 18 22 15 10 12 7 Q1 Q1 Q2 Q2 Q3 Q3 Q4 Q4 2004 2005 2004 2005 2004 2005 2004 2005 Striving f
Slide 7: Dräger Medical 9M 2005: Capital Employed
Dräger Medical 9M 2005: Capital Employed mn € 9M 2004 9M 2005 Change Capital Employed 534.6 568.6 +6.4% Investments 19.0 15.1 -20.5% 535 563 562 569 569 Capital 479 458 507 Employed mn € 12.2003 03.2004 06.2004 09.2004 12.2004 03.2005 06.2005 09.2005 Stable Capital Employed despite double-digit grow
Slide 8: Dräger Medical Regional Sales Split 9M 2004/9M 2005
Dräger Medical Regional Sales Split 9M 2004/ 9M 2005 Regional Sales Split Regional Sales Split 9M 2004 9M 2005 Other Other 5% 6% Asia-Pacific Asia-Pacific Germany Germany 12% 13% 23% 28% Americas Americas 19% 22% Europe Europe 36% 36% Contribution of home market Germany continues to shrink 8 Novembe
Slide 9: Dräger Safety
Dräger Safety »Pioneering Solutions« 9 November 05
Slide 10: Dräger Safety Highlights Q3 2005
Dräger Safety Highlights Q3 2005 • Growth mainly based on volume business • Higher than proportional increase in EBIT • Innovation push continues - Approval of Dräger Alcotest 6510 in the UK - New technology center in Blyth, UK - New generation of portable gas detection systems • Expenses for R&D co
Slide 11: Dräger Safety Q3 2005 / 9M 2005
Dräger Safety Q3 2005 / 9M 2005 mn € Q3 2004 Q3 2005 Change 9M 2004 9M 2005 Change Order entry 122.1 136.9 +12.1% 383.9 414.6 +8.0% Net sales 116.4 127.0 +9.1% 357.3 391.3 +9.5% Operating EBIT * 6.7 8.1 +20.9% 28.0 32.1 +14.6% EBIT margin 5.8% 6.4% 7.8% 8.2% *Incl. non-recurring gains 0.0 0.0 0.0 2.
Slide 12: Dräger Safety Key Figures/Development
Dräger Safety Key Figures/ Development +/- 7% 503 Net Sales mn € 357 391* *Incl. Interservices 241 264 (18.3mn €) 141 146 113 123 128 116 127 Q1 Q1 Q2 Q2 Q3 Q3 Q4 Q4 2004 2005 2004 2005 2004 2005 2004 2005 +7-10% EBIT 41 mn € 28 32 * 21 24 * *Incl. InTek 13 (2.1mn €) 10 11* 11 13 7 8 Q1 Q1 Q2 Q2 Q3
Slide 13: Dräger Safety 9M 2005: Capital Employed
Dräger Safety 9M 2005: Capital Employed mn € 9M 2004 9M 2005 Change Capital Employed 176.4 193.0 +9.4% Investments 14.5 19.1 +31.7% 190 193 Capital 170 176 176 Employed 154 156 157 mn € 12.2003 03.2004 06.2004 09.2004 12.2004 03.2005 06.2005 09.2005 Increasing Capital Employed mainly due to higher i
Slide 14: Dräger Safety Regional Sales Split 9M 2004/9M 2005
Dräger Safety Regional Sales Split 9M 2004/ 9M 2005 Regional Sales Split Regional Sales Split 9M 2004 9M 2005 Other Other Asia-Pacific 4% 3% 12% Germany Asia-Pacific 11% Germany 21% 26% Americas 19% Americas 16% Europe Europe 44% 44% Strong growth in Germany 14 November 05
Slide 15: Dräger Group
Dräger Group 15 November 05
Slide 16: Dräger Group Q3 2005 / 9M 2005
Dräger Group Q3 2005 / 9M 2005 mn € Q3 2004 Q3 2005 Change 9M 2004 9M 2005 Change Order entry 367.8 404.7 +10.0% 1,084.8 1,211.5 +11.7% Net sales 341.4 374.3 +9.6% 1,016.4 1,114.2 +9.6% Gross margin 48.1% 48.3% 49.5% 49.3% Operating EBIT 14.9 19.1 +28.2% 59.8 66.7 +11.5% EBIT margin 4.4% 5.1% 5.9% 6
Slide 17: Dräger Group 9M 2005
Dräger Group 9M 2005 mn € 9M 2004 9M 2005 Change Capital Employed 800.2 845.3 +5.6% Investments 39.1 37.1 -5.1% Free Cash Flow -82.3 -16.9 Net financial debt 233.9 263.5 +12.7% Capital 800 804 846 845 748 793 694 678 Employed mn € 12.2003 03.2004 06.2004 09.2004 12.2004 03.2005 06.2005 09.2005 Stabl
Slide 18: Capital Employed 12.2004 / 09.2005
Dräger Group Capital Employed 12.2004/ 09.2005 +7% 845.3 792.9 329.8 260.4 +27% 455.6 417.3 -8% 452.1 452.0 474.2 +5% Inventories -375.2 -376.0 Trade receivables Other CE Assets CE Deduction Capital 12.2004 09.2005 18 November 05
Slide 19: Cash Flow Statement 9M 2004/9M 2005
Dräger Group Cash Flow Statement 9M 2004/ 9M 2005 Operating Investing Financing Change in activities activities activities cash 64.1 mn € 2.0 15.3 -18.9 -18.2 -1.6 -24.2 -58.1 9M 2004 9M 2005 19 November 05
Slide 20: Outlook / Net Sales
Dräger Group Outlook/ Net Sales Dräger Medical mn € Dräger Safety >= 7% +/- 7% 1,023 477 503 920 391 747 357 662 9M 2003 2004 2005e 2003 2004 2005e Holding/ Consolidation mn € Dräger Group + 5-7% 2003 2004 2005e 25 1,521 1,422 -4 1,114 9M 1,016 -6 -25 20 November 05 -35...-40 2003 2004 2005e
Slide 21: Outlook / Operating EBIT
Dräger Group Outlook/ Operating EBIT Dräger Medical mn € Dräger Safety >= 7% + 7-10% 94 41 85 37 32 28 9M 49 35 2003 2004 2005e 2003 2004 2005e Holding/ Consolidation mn € Dräger Group 2003 2004 2005e + 5-10% -3 117 95 -15 9M 67 -18 60 -27 -20…-25 2003 2004 2005e 21 November 05
Slide 22: Appendix
Appendix 22 November 05
Slide 23: IFRS: Reconciliation of Equity by September 30, 2004
9M-Report Dräger Group IFRS: Reconciliation of Equity by September 30, 2004 mn € 30.09.2004 Equity under HGB (incl. minority interests) 517.8 Asset-backed securities -2.5 Recognition of internally developed Software 2.0 Goodwill 5.7 Valuation adjustment of components/ adjustment of depreciation -2.0
Slide 24: IFRS: Reconciliation of Net Income by September 30, 2004
9M-Report Dräger Group IFRS: Reconciliation of Net Income by September 30, 2004 mn € 30.09.2004 Net income under HGB (incl. minority interests) 26.6 Recognition/Valuation adjustment of internally developed Software -0.6 Valuation adjustment of components/ adjustment of depreciation -0.3 Inventory me
Slide 25: Disclaimer
Disclaimer Estimates: This presentation contains a number of forecasts and estimates which are based on present expectations, anticipations and predictions on the part of the Executive Board and the information it currently has. Such estimates should not be construed as a warranty that the future de
Drägerwerk AG & Co. KGaA — Q3 2005 Earnings Presentation on 6ix